Related Experiment Video
Updated: Jan 15, 2026
03:30
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
2.4K
Patient-Reported Long-Term Outcomes of Laparoscopic Sacrocolpopexy
Georgina Baines1,2, Panos Safioleas3, Joanna Hill4
1Oxford University Hospital, Oxford, UK. georgina.baines@ouh.nhs.uk.
International Urogynecology Journal
|October 13, 2025
Summary
Laparoscopic mesh sacrocolpopexy (LSC) for prolapse has a low reoperation rate (1.5%) for mesh complications after nearly 10 years. Most women report improved symptoms, indicating LSC is a safe and effective long-term treatment option.
Area of Science:
- Urogynecology
- Pelvic reconstructive surgery
- Surgical outcomes research
Background:
- Laparoscopic mesh sacrocolpopexy (LSC) is a key surgical option for treating post-hysterectomy vault prolapse.
- While effective, concerns exist regarding long-term adverse events (AEs) associated with non-absorbable mesh used in LSC.
- Limited long-term data exists on mesh-related AEs following LSC.
Purpose of the Study:
- To determine the incidence of mesh-related AEs requiring reoperation after LSC.
- To evaluate long-term patient-reported outcomes, including pain and prolapse symptom recurrence, following LSC.
Main Methods:
- A cross-sectional postal questionnaire study was conducted.
- Data was collected from women who underwent LSC between 2011 and 2023 at a UK tertiary center.
- Surgical databases were used to identify eligible participants.
Main Results:
- A 58% response rate was achieved from 574 identified women, with a median follow-up of 116 months.
- The rate of reoperation for mesh-related AEs was 1.5% (n=5).
- 3% reported mesh-related pain requiring pain specialist care; 70.4% reported significant symptom improvement, while 5.7% reported worsening symptoms.
Conclusions:
- LSC demonstrates a low risk of reoperation for mesh-related AEs (1.5%) at nearly 10 years post-surgery.
- Rates of chronic pain service utilization due to mesh complications are low.
- The study provides reassuring long-term safety and efficacy data for LSC, supporting patient counseling for post-hysterectomy vault prolapse treatment.
